Evaluation of Perfusion Index Change Post Passive Leg Raising for Fluid Responsiveness in Critically Ill

Evaluation of Pulse-oximetry Derived Perfusion Index Change Post Passive Leg Raising for Fluid Responsiveness in Critically Ill Patients

Peripheral Perfusion Index (PI) has been investigated for its use in hemodynamic monitoring. The PI is derived from the photoelectric plethysmographic signal of the pulse oximeter. The changes in the PI reflect changes in peripheral vasomotor tone.

In critically ill patients, the same value was found to represent a very sensitive cutoff point for determining abnormal peripheral perfusion, as defined by a prolonged Capillary Refill Time (CRT). However, age, gender, and ambient temperature have all been shown to affect the measure of CRT in normal volunteers, and the presence of a CRT > 2 or 3 seconds was not predictive of blood loss in phlebotomized volunteers. In addition, the CRT has been shown to have poor intra-observer agreement when a cutoff a two seconds was used in adult emergency room patients.13 Therefore, PI can be used for monitoring peripheral perfusion in critically ill patients.14PI shows the perfusion status of the tissue in the applied area for an instant and a certain time interval. The PI value ranges from 0.02% (very weak) to 20% (strong).

As non-invasive CO monitors (ICON ®) is not available in many centers in our country due to its high cost, we try to validate other simple non-invasive method to be used to assess FR in critically ill patients.

The purpose of this study is to investigate the efficacy of pulse-oximeter derived PI measurement in assessment of fluid responsiveness in critically ill patients in comparison with CO response.

Study Overview

Status

Recruiting

Detailed Description

After approval by NHTMRI-IRB Ethical Committee.All demographic data will be obtained including the patients age, sex,associated co-morbidities (diabetes mellitus & hypertension).

Continuous blood pressure, continuous electrocardiogram, heart rate (HR), and SpO2 (measured by pulse oximetry).

Patients who are eligible and have signs of hemodynamic instability, PLR will be performed by adjusting the bed and not by manually raising the patient's legs. Bronchial secretions must be carefully aspirated before PLR. If awake, the patient should be informed of what the test involves.PLR should start from the semi-recumbent and not the supine position. Adding trunk lowering tosupine position and leg raisingfor 45° for 60 seconds, this mobilizes venous blood from the large splanchnic compartment, thus magnifying the increasing effects of leg elevation on cardiac preload.18COand PI measurements will be recorded in the same patients.

Study Type

Observational

Enrollment (Estimated)

56

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Cairo, Egypt, 4260010
        • Recruiting
        • NHTMRI
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population will be subdivided into two groups; responders and non-responder:

  • Responders group 1 (R); were defined as those who had increase of 10% in CO from baseline measured by EC after PLR.
  • Non-responders group 2 (NR); those who had increase of less than 10% in CO from baseline measured by EC after PLR.

Description

Inclusion Criteria:

  • The subjects are adults aged ≥18 years old
  • admitted tothe intensive care unit of the National Hepatologyand Tropical Medicine Research Institute (NHTMRI).
  • Patients with clinical signs of hemodynamic instability i.e. a systolic blood pressure < 90 mmHg or decrease in systolic blood pressure > 40 mmHg, signs of organ hypoperfusion as oliguria < 0.5ml/Kg/hour.

Exclusion Criteria:

  • If there is known peripheral vascular disease
  • or ≥ 2 vasopressors with the maximum doses
  • or in the presence of nail polish as readings from pulse oximeter will be distortedin these cases
  • or if there is contraindication for PLR as uncontrolled hemodynamic status
  • intracranial hypertension
  • severe chronic obstructive pulmonary disease
  • broncho-alveolar fistula
  • severe emphysema
  • and those with pre-existing comorbidities including severe left and right ventricular dysfunction, severe pulmonary hypertension
  • severe obesity (BMI >40 kg/m2)
  • pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fluid responsiveness
Time Frame: during PLR passive leg raising during 60 seconds
to detect reliability of PI to detect Fluid responsiveness (FR) in critically ill patients
during PLR passive leg raising during 60 seconds

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PI reliability
Time Frame: by the end of statistical analysis of the study up to one year
obtain the sensitivity and specificity of this index for FR.
by the end of statistical analysis of the study up to one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 28, 2023

Primary Completion (Estimated)

September 1, 2024

Study Completion (Estimated)

January 1, 2025

Study Registration Dates

First Submitted

August 28, 2023

First Submitted That Met QC Criteria

September 28, 2023

First Posted (Actual)

October 3, 2023

Study Record Updates

Last Update Posted (Actual)

October 3, 2023

Last Update Submitted That Met QC Criteria

September 28, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 27-2023

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fluid Responsiveness

3
Subscribe